Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 38% ± 17% | |
lung | 13 studies | 24% ± 8% | |
peripheral blood | 13 studies | 25% ± 6% | |
eye | 9 studies | 28% ± 10% | |
kidney | 6 studies | 24% ± 6% | |
intestine | 5 studies | 20% ± 7% | |
uterus | 5 studies | 28% ± 10% | |
pancreas | 4 studies | 51% ± 24% | |
bone marrow | 4 studies | 19% ± 3% | |
breast | 4 studies | 20% ± 5% | |
adipose | 3 studies | 22% ± 4% | |
lymph node | 3 studies | 22% ± 1% | |
liver | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 31789.16 | 2642 / 2642 | 100% | 561.34 | 704 / 705 |
breast | 100% | 19779.31 | 459 / 459 | 99% | 334.79 | 1108 / 1118 |
lung | 100% | 16384.15 | 576 / 578 | 99% | 182.35 | 1146 / 1155 |
esophagus | 99% | 12737.75 | 1436 / 1445 | 99% | 163.51 | 182 / 183 |
thymus | 100% | 16439.92 | 653 / 653 | 98% | 358.26 | 592 / 605 |
adrenal gland | 100% | 19830.07 | 258 / 258 | 98% | 588.88 | 225 / 230 |
prostate | 100% | 10527.49 | 244 / 245 | 98% | 263.94 | 492 / 502 |
kidney | 100% | 9605.08 | 89 / 89 | 97% | 321.87 | 873 / 901 |
stomach | 100% | 9580.12 | 358 / 359 | 97% | 140.61 | 277 / 286 |
intestine | 100% | 13576.32 | 965 / 966 | 95% | 138.41 | 499 / 527 |
uterus | 100% | 16463.99 | 170 / 170 | 94% | 142.14 | 432 / 459 |
skin | 100% | 13357.29 | 1806 / 1809 | 94% | 220.63 | 444 / 472 |
bladder | 100% | 13535.24 | 21 / 21 | 92% | 129.83 | 465 / 504 |
liver | 98% | 7438.69 | 221 / 226 | 94% | 144.99 | 381 / 406 |
ovary | 100% | 14459.21 | 180 / 180 | 87% | 93.88 | 374 / 430 |
pancreas | 84% | 4684.61 | 274 / 328 | 98% | 214.39 | 174 / 178 |
adipose | 100% | 21925.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 24389.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 13186.22 | 802 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8621.18 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 94% | 10497.19 | 813 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 129.77 | 40 / 45 |
peripheral blood | 88% | 8063.20 | 820 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 145.89 | 69 / 80 |
lymph node | 0% | 0 | 0 / 0 | 76% | 83.27 | 22 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1904219 | Biological process | positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity |
GO_0006658 | Biological process | phosphatidylserine metabolic process |
GO_0008654 | Biological process | phospholipid biosynthetic process |
GO_0044091 | Biological process | membrane biogenesis |
GO_1904222 | Biological process | positive regulation of serine C-palmitoyltransferase activity |
GO_0006665 | Biological process | sphingolipid metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SERINC1 |
Protein name | Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2) |
Synonyms | KIAA1253 UNQ396/PRO732 TDE2 TDE1L |
Description | FUNCTION: Enhances the incorporation of serine into phosphatidylserine and sphingolipids. . |
Accessions | ENST00000339697.5 Q9NRX5 |